Atlas Trials

Relapsed and Refractory

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed and Refractory

RecordFirmDate
Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurrent or Refractory B Cell Non-Hodgkin Lymphoma (NCT04626908)He Huang2020-11-20
A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies (NCT04283006)He Huang2018-05-23
Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma (NCT03376958)Zhengzhou University2017-01-01
Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma (NCT02282358)Memorial Sloan Kettering Cancer Center2014-10-01

Track Relapsed and Refractory automatically

Every clearance here is in the API, with alerts when new ones post.